<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">nnp</journal-id><journal-title-group><journal-title xml:lang="en">Neurology, Neuropsychiatry, Psychosomatics</journal-title><trans-title-group xml:lang="ru"><trans-title>Неврология, нейропсихиатрия, психосоматика</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-2711</issn><issn pub-type="epub">2310-1342</issn><publisher><publisher-name>"IMA-Press", LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/2074-2711-2024-2S-31-37</article-id><article-id custom-type="elpub" pub-id-type="custom">nnp-2313</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL INVESTIGATIONS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ И МЕТОДИКИ</subject></subj-group></article-categories><title-group><article-title>Global transcriptome profiling of blood mononuclear cells from individuals with radiologically isolated syndrome reveals abnormalities characteristic of the rapid manifestation of multiple sclerosis symptoms</article-title><trans-title-group xml:lang="ru"><trans-title>Полнотранскриптомное профилирование мононуклеарных клеток крови пациентов с радиологически изолированным синдромом позволяет выявить нарушения, характерные для скорой манифестации симптомов рассеянного склероза</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6587-1243</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козин</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozin</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Максим Сергеевич Козин</p><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, ул. 3-я Черепковская, 15А</p></bio><bio xml:lang="en"><p>Maksim Sergeevich Kozin</p><p>1, Ostrovityanova St., Moscow 117997; National Medical Research Center for Cardiology, Ministry of Health of Russia</p></bio><email xlink:type="simple">kozinmax1992@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0982-8520</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кабаева</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Kabaeva</surname><given-names>A. R.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1, стр. 10</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Build. 10, Moscow 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6744-2191</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Омарова</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Omarova</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1, стр. 10</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Build. 10, Moscow 117997</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2975-4151</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойко</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Boyko</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1; 117997, Москва, ул. Островитянова, 1, стр. 10</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Moscow 117997; 1, Ostrovityanova St., Build. 10, Moscow 117997</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5271-6698</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фаворова</surname><given-names>О. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Favorova</surname><given-names>O. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, ул. 3-я Черепковская, 15А</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Moscow 117997; National Medical Research Center for Cardiology, Ministry of Health of Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5321-3101</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулакова</surname><given-names>О. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulakova</surname><given-names>O. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>117997, Москва, ул. Островитянова, 1; 121552, Москва, ул. 3-я Черепковская, 15А</p></bio><bio xml:lang="en"><p>1, Ostrovityanova St., Moscow 117997; National Medical Research Center for Cardiology, Ministry of Health of Russia</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ФГБУ «Национальный медицинский исследовательский центр кардиологии им. акад. Е.И. Чазова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; National Medical Research Center for Cardiology, Ministry of Health of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России; ФГБУ «Федеральный центр мозга и нейротехнологий» ФМБА России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; Federal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>07</day><month>08</month><year>2024</year></pub-date><volume>16</volume><issue>0</issue><issue-title>(Suppl. 2)</issue-title><fpage>31</fpage><lpage>37</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kozin M.S., Kabaeva A.R., Omarova M.A., Boyko A.N., Favorova O.O., Kulakova O.G., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Козин М.С., Кабаева А.Р., Омарова М.А., Бойко А.Н., Фаворова О.О., Кулакова О.Г.</copyright-holder><copyright-holder xml:lang="en">Kozin M.S., Kabaeva A.R., Omarova M.A., Boyko A.N., Favorova O.O., Kulakova O.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://nnp.ima-press.net/nnp/article/view/2313">https://nnp.ima-press.net/nnp/article/view/2313</self-uri><abstract><sec><title>Objective</title><p>Objective: to look for differences in the transcriptome profiles in mononuclear blood cells of a group of patients with radiologically isolated syndrome (RIS) who developed symptoms of multiple sclerosis (MS) in the following three years of observation and a group of patients with RIS who did not develop MS during this period.</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 19 patients with RIS (9 men and 10 women), six of whom developed symptoms of MS during the three-year follow-up period. The transcription profiles of blood mononuclear cells were compared between the groups of patients with RIS who developed or did not develop MS symptoms during this period. The work was conducted in the format of a prospective study; the time of blood collection was taken as the reference point. Full transcriptome profiling was performed using RNA sequencing on an MGISEQ-200 platform. Differential gene expression analysis was performed using the DESeq2 package for the R programming language. Subsequent analysis involved constructing a network of interactions between the protein products of the detected differentially expressed genes based on data from the STRING database, identifying a cluster of interacting proteins, and analyzing the enrichment of this cluster by participants in pathways annotated in the KEGG database.</p></sec><sec><title>Results</title><p>Results. The expression of 146 genes differed significantly (p&lt;0.05; |log2FC| &gt;1) in the studied groups of patients with RIS: in patients with subsequent manifestation of MS symptoms, the expression of 67 genes was lower and expression of 79 genes was higher than in patients without MS symptoms. The decrease in expression of two of the 67 genes (ADGRG7 and LGALS9C) remained significant even after correction for multiple comparisons (padj=2.17⋅10-11 and padj=6.19⋅10-6, respectively). Analyzing the network of interactions between the protein products of the differentially expressed genes allowed the identification of a cluster of 12 genes: APBB2, CCL4, CCL4L2, CDH2, DAZL, FOSB, H2BC17, JUN, KLF4, KLF5, MAPK8IP1, SYCE1; it is over-represented by components of the Toll-like receptor signaling pathway.</p></sec><sec><title>Conclusion</title><p>Conclusion. The transcriptome profiles of blood mononuclear cells differ in groups of patients with RIS who did or did not develop MS symptoms during the three-year follow-up period. The decrease in the expression level of ADGRG7 and LGALS9C genes detected in this study as a sign of rapid conversion of RIS to MS needs to be confirmed in independent samples.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Цель исследования – поиск в мононуклеарных клетках крови различий транскрипционных профилей группы лиц с радиологически изолированным синдромом (РИС), у которых в последующие три года наблюдения произошла манифестация симптомов рассеянного склероза (РС), и группы пациентов с РИС, у которых за это время манифестации симптомов РС не произошло.</p><sec><title>Материал и методы</title><p>Материал и методы. В исследование включены 19 пациентов с РИС (9 мужчин и 10 женщин), из которых у шести за три года наблюдения произошла манифестация симптомов РС. Проведено сравнение профилей транскрипции мононуклеарных клеток крови между группами пациентов с РИС, у которых за это время проявились или не проявились симптомы РС. Работу проводили в формате проспективного исследования; время сбора образцов крови принимали за точку отсчета. Полнотранскриптомное профилирование выполняли методом секвенирования РНК на приборе MGISEQ-200. Анализ дифференциальной экспрессии генов осуществляли при помощи пакета DESeq2 для языка программирования R. Последующий анализ включал построение сети взаимодействий белковых продуктов обнаруженных дифференциально экспрессированных генов на основе данных базы STRING, выделение кластера взаимодействующих белков и анализ обогащения этого кластера участниками путей, аннотированных в базе данных KEGG.</p></sec><sec><title>Результаты</title><p>Результаты. Экспрессия 146 генов значимо (p&lt;0,05; |log2FC| &gt;1) различалась в исследуемых группах пациентов с РИС: у пациентов с последующей манифестацией симптомов РС экспрессия 67 генов была ниже, а 79 – выше, чем у пациентов без симптомов РС.</p><p>Снижение экспрессии двух генов из 67 (ADGRG7 и LGALS9C) оставалось значимым при использовании поправки на множественное сравнение (padj=2,17⋅10-11 и padj=6,19⋅10-6 соответственно). Анализ сети взаимодействий белковых продуктов дифференциально экспрессирующихся генов позволил выделить кластер, включающий 12 генов: APBB2, CCL4, CCL4L2, CDH2, DAZL, FOSB, H2BC17, JUN, KLF4, KLF5, MAPK8IP1, SYCE1; он перепредставлен компонентами пути “Toll-like receptor signaling pathway”.</p></sec><sec><title>Заключение</title><p>Заключение. Профили транскрипции мононуклеарных клеток крови различаются в группах пациентов с РИС, у которых за три года последующего наблюдения произошла или не произошла манифестация симптомов РС. Возможность использовать снижение уровней экспрессии генов ADGRG7 и LGALS9C, обнаруженное в настоящей работе, в качестве признака скорой конверсии РИС в РС требует подтверждения на независимых выборках.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>радиологически изолированный синдром</kwd><kwd>рассеянный склероз</kwd><kwd>секвенирование РНК</kwd><kwd>транскриптом</kwd><kwd>мононуклеарные клетки периферической крови</kwd><kwd>анализ путей</kwd></kwd-group><kwd-group xml:lang="en"><kwd>radiologically isolated syndrome</kwd><kwd>multiple sclerosis</kwd><kwd>RNA sequencing</kwd><kwd>transcriptome</kwd><kwd>peripheral blood mononuclear cells</kwd><kwd>pathway analysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено за счет гранта Российского научного фонда № 23-75-01109 (https://rscf.ru/project/23-75-01109/). Исследование не имело спонсорской поддержки</funding-statement><funding-statement xml:lang="en">The study was supported by Russian Science Foundation grant No. 23-75-01109 (https://rscf.ru/project/23-75-01109/). The investigation has not been sponsored</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 Mar 3;72(9):800-5. doi: 10.1212/01.wnl.0000335764.14513.1a. Epub 2008 Dec 10. Erratum in: Neurology. 2009 Apr 7;72(14):1284.</mixed-citation><mixed-citation xml:lang="en">Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology. 2009 Mar 3;72(9):800-5. doi: 10.1212/01.wnl.0000335764.14513.1a. Epub 2008 Dec 10. Erratum in: Neurology. 2009 Apr 7;72(14):1284.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lebrun-Frenay C, Kantarci O, Siva A, et al; 10-year RISC study group on behalf of SFSEP, OFSEP. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020 Aug;88(2):407-17. doi: 10.1002/ana.25799. Epub 2020 Jun 29.</mixed-citation><mixed-citation xml:lang="en">Lebrun-Frenay C, Kantarci O, Siva A, et al; 10-year RISC study group on behalf of SFSEP, OFSEP. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020 Aug;88(2):407-17. doi: 10.1002/ana.25799. Epub 2020 Jun 29.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lebrun-Frenay C, Siva A, Sormani MP, et al; TERIS Study Group. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023 Oct 1;80(10):1080-8. doi: 10.1001/jamaneurol.2023.2815</mixed-citation><mixed-citation xml:lang="en">Lebrun-Frenay C, Siva A, Sormani MP, et al; TERIS Study Group. Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial. JAMA Neurol. 2023 Oct 1;80(10):1080-8. doi: 10.1001/jamaneurol.2023.2815</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda DT, Kantarci O, Lebrun-Frenay C, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023 Mar;93(3):604-14. doi: 10.1002/ana.26555. Epub 2022 Dec 10.</mixed-citation><mixed-citation xml:lang="en">Okuda DT, Kantarci O, Lebrun-Frenay C, et al. Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome. Ann Neurol. 2023 Mar;93(3):604-14. doi: 10.1002/ana.26555. Epub 2022 Dec 10.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Preziosa P, Rocca MA, Filippi M. Radiologically isolated syndromes: to treat or not to treat? J Neurol. 2024 May;271(5):2370-8. doi: 10.1007/s00415-024-12294-4. Epub 2024 Mar 19.</mixed-citation><mixed-citation xml:lang="en">Preziosa P, Rocca MA, Filippi M. Radiologically isolated syndromes: to treat or not to treat? J Neurol. 2024 May;271(5):2370-8. doi: 10.1007/s00415-024-12294-4. Epub 2024 Mar 19.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda DT, Siva A, Kantarci O, et al; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la SclОrose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509</mixed-citation><mixed-citation xml:lang="en">Okuda DT, Siva A, Kantarci O, et al; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la SclОrose en Plaques (CFSEP). Radiologically isolated syndrome: 5-year risk for an initial clinical event. PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Okuda DT, Lebrun-Frenay C. Radiologically isolated syndrome in the spectrum of multiple sclerosis. Mult Scler. 2024 May;30(6):630-6. doi: 10.1177/13524585241245306. Epub 2024 Apr 15.</mixed-citation><mixed-citation xml:lang="en">Okuda DT, Lebrun-Frenay C. Radiologically isolated syndrome in the spectrum of multiple sclerosis. Mult Scler. 2024 May;30(6):630-6. doi: 10.1177/13524585241245306. Epub 2024 Apr 15.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Кабаева АР, Бойко АН, Кулакова ОГ, Фаворова ОО. Радиологически изолированный синдром: прогноз и предикторы 2020;120(7-2):7-12. doi: 10.17116/jnevro20201200727</mixed-citation><mixed-citation xml:lang="en">Kabaeva AR, Boyko AN, Kulakova OG, Favorova OO. Radiologically isolated syndrome: prognosis and predictors of conversion to multiple sclerosis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(7-2):7-12. doi: 10.17116/jnevro20201200727 (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kozin M, Kiselev I, Baulina N, et al. Global transcriptome profiling in peripheral blood mononuclear cells identifies dysregulation of immune processes in individuals with radiologically isolated syndrome. Mult Scler Relat Disord. 2022 Feb;58:103469. doi: 10.1016/j.msard.2021.103469. Epub 2021 Dec 20.</mixed-citation><mixed-citation xml:lang="en">Kozin M, Kiselev I, Baulina N, et al. Global transcriptome profiling in peripheral blood mononuclear cells identifies dysregulation of immune processes in individuals with radiologically isolated syndrome. Mult Scler Relat Disord. 2022 Feb;58:103469. doi: 10.1016/j.msard.2021.103469. Epub 2021 Dec 20.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Munoz-San Martin M, Torras S, Robles-Cedeno R, et al. Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers. Epigenomics. 2020 Dec;12(23):2065-76. doi: 10.2217/epi-2020-0172. Epub 2020 Dec 8.</mixed-citation><mixed-citation xml:lang="en">Munoz-San Martin M, Torras S, Robles-Cedeno R, et al. Radiologically isolated syndrome: targeting miRNAs as prognostic biomarkers. Epigenomics. 2020 Dec;12(23):2065-76. doi: 10.2217/epi-2020-0172. Epub 2020 Dec 8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005 Jun;62(6):865-70. doi: 10.1001/arch-neur.62.6.865</mixed-citation><mixed-citation xml:lang="en">Freedman MS, Thompson EJ, Deisenhammer F, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005 Jun;62(6):865-70. doi: 10.1001/arch-neur.62.6.865</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. doi: 10.1093/nar/gkaa1074. Erratum in: Nucleic Acids Res. 2021 Oct 11;49(18):10800. doi: 10.1093/nar/gkab835</mixed-citation><mixed-citation xml:lang="en">Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612. doi: 10.1093/nar/gkaa1074. Erratum in: Nucleic Acids Res. 2021 Oct 11;49(18):10800. doi: 10.1093/nar/gkab835</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">MacQueen J. Some methods for classification and analysis of multivariate observations. Berkeley Symp Math Stat Prob. 1967;1967:281-97.</mixed-citation><mixed-citation xml:lang="en">MacQueen J. Some methods for classification and analysis of multivariate observations. Berkeley Symp Math Stat Prob. 1967;1967:281-97.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic</mixed-citation><mixed-citation xml:lang="en">Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sameer AS, Nissar S. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. Biomed Res Int. 2021 Sep 12;2021:1157023. doi: 10.1155/2021/1157023</mixed-citation><mixed-citation xml:lang="en">Sameer AS, Nissar S. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. Biomed Res Int. 2021 Sep 12;2021:1157023. doi: 10.1155/2021/1157023</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Jafarzadeh A, Nemati M, Khorramdelazad H, Mirshafiey A. The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Iran J Allergy Asthma Immunol. 2019 Jun 8;18(3):230-50. doi: 10.18502/ijaai.v18i3.1117</mixed-citation><mixed-citation xml:lang="en">Jafarzadeh A, Nemati M, Khorramdelazad H, Mirshafiey A. The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Iran J Allergy Asthma Immunol. 2019 Jun 8;18(3):230-50. doi: 10.18502/ijaai.v18i3.1117</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Podda G, Nyirenda M, Crooks J, Gran B. Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis. J Neuroimmune Pharmacol. 2013 Sep;8(4):791-806. doi: 10.1007/s11481-013-9483-3. Epub 2013 Jun 28.</mixed-citation><mixed-citation xml:lang="en">Podda G, Nyirenda M, Crooks J, Gran B. Innate immune responses in the CNS: role of toll-like receptors, mechanisms, and therapeutic opportunities in multiple sclerosis. J Neuroimmune Pharmacol. 2013 Sep;8(4):791-806. doi: 10.1007/s11481-013-9483-3. Epub 2013 Jun 28.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Vastrad B, Vastrad C. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis. bioRxiv. 2023. doi: 10.1101/2023.12.05.570305</mixed-citation><mixed-citation xml:lang="en">Vastrad B, Vastrad C. Identification of candidate biomarkers and pathways associated with multiple sclerosis using bioinformatics and next generation sequencing data analysis. bioRxiv. 2023. doi: 10.1101/2023.12.05.570305</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med. 2008 Jun 13;10:e17. doi: 10.1017/S1462399408000719</mixed-citation><mixed-citation xml:lang="en">Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med. 2008 Jun 13;10:e17. doi: 10.1017/S1462399408000719</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Sato M, Nishi N, Shoji H, et al. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology. 2002 Mar;12(3):191-7. doi: 10.1093/glycob/12.3.191</mixed-citation><mixed-citation xml:lang="en">Sato M, Nishi N, Shoji H, et al. Functional analysis of the carbohydrate recognition domains and a linker peptide of galectin-9 as to eosinophil chemoattractant activity. Glycobiology. 2002 Mar;12(3):191-7. doi: 10.1093/glycob/12.3.191</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Troncoso MF, Elola MT, Blidner AG, et al. The universe of galectin-binding partners and their functions in health and disease. J Biol Chem. 2023 Dec;299(12):105400. doi: 10.1016/j.jbc.2023.105400. Epub 2023 Oct 26.</mixed-citation><mixed-citation xml:lang="en">Troncoso MF, Elola MT, Blidner AG, et al. The universe of galectin-binding partners and their functions in health and disease. J Biol Chem. 2023 Dec;299(12):105400. doi: 10.1016/j.jbc.2023.105400. Epub 2023 Oct 26.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Nio-Kobayashi J, Itabashi T. Galectins and Their Ligand Glycoconjugates in the Central Nervous System Under Physiological and Pathological Conditions. конверсии в рассеянный склероз. Журнал неврологии и психиатрии им. С.С. Корсакова. Acids Res. 2000 Jan 1;28(1):27-30. doi: 10.1093/nar/28.1.27 Front Neuroanat. 2021 Oct 15;15:767330. doi: 10.3389/fnana.2021.767330</mixed-citation><mixed-citation xml:lang="en">Nio-Kobayashi J, Itabashi T. Galectins and Their Ligand Glycoconjugates in the Central Nervous System Under Physiological and Pathological Conditions. конверсии в рассеянный склероз. Журнал неврологии и психиатрии им. С.С. Корсакова. Acids Res. 2000 Jan 1;28(1):27-30. doi: 10.1093/nar/28.1.27 Front Neuroanat. 2021 Oct 15;15:767330. doi: 10.3389/fnana.2021.767330</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ramos-Martinez E, Ramos-Martinez I, Sanchez-Betancourt I, et al. Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and MetaAnalysis. Biomolecules. 2022 Jul 31;12(8):1062 doi: 10.3390/biom12081062</mixed-citation><mixed-citation xml:lang="en">Ramos-Martinez E, Ramos-Martinez I, Sanchez-Betancourt I, et al. Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and MetaAnalysis. Biomolecules. 2022 Jul 31;12(8):1062 doi: 10.3390/biom12081062</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kandel S, Adhikary P, Li G, Cheng K. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy. Cancer Lett. 2021 Jul 10;510:67-78. doi: 10.1016/j.canlet.2021.04.011. Epub 2021 Apr 22.</mixed-citation><mixed-citation xml:lang="en">Kandel S, Adhikary P, Li G, Cheng K. The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy. Cancer Lett. 2021 Jul 10;510:67-78. doi: 10.1016/j.canlet.2021.04.011. Epub 2021 Apr 22.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol. 2006 Dec;18(6):665-9. doi: 10.1016/j.coi.2006.09.009. Epub 2006 Oct 2.</mixed-citation><mixed-citation xml:lang="en">Anderson AC, Anderson DE. TIM-3 in autoimmunity. Curr Opin Immunol. 2006 Dec;18(6):665-9. doi: 10.1016/j.coi.2006.09.009. Epub 2006 Oct 2.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson DE. TIM-3 as a therapeutic target in human inflammatory diseases. Expert Opin Ther Targets. 2007 Aug;11(8):1005-9. doi: 10.1517/14728222.11.8.1005</mixed-citation><mixed-citation xml:lang="en">Anderson DE. TIM-3 as a therapeutic target in human inflammatory diseases. Expert Opin Ther Targets. 2007 Aug;11(8):1005-9. doi: 10.1517/14728222.11.8.1005</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Feng X, Feng J. Clinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis. J Clin Neurosci. 2016 Dec;34:193-7. doi: 10.1016/j.jocn.2016.07.007. Epub 2016 Aug 17.</mixed-citation><mixed-citation xml:lang="en">Feng X, Feng J. Clinical significance of Tim3-positive T cell subsets in patients with multiple sclerosis. J Clin Neurosci. 2016 Dec;34:193-7. doi: 10.1016/j.jocn.2016.07.007. Epub 2016 Aug 17.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Saresella M, Piancone F, Marventano I, et al. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 2014 Nov;28(11):5000-9. doi: 10.1096/fj.14-258194. Epub 2014 Aug 4.</mixed-citation><mixed-citation xml:lang="en">Saresella M, Piancone F, Marventano I, et al. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis. FASEB J. 2014 Nov;28(11):5000-9. doi: 10.1096/fj.14-258194. Epub 2014 Aug 4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
